Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Competitive pricing on individual peptides, with blends at the premium end
ran early-phase ulcerative colitis trials (PL 14736 designation)
Private insurers may have their own requirements
Any dose-finding data published before 2023, including early cagrilintide monotherapy work, should be treated as preliminary relative to the current fixed-ratio Phase 3 dataset
Define your goals clearly
Higher Doses: IV infusions may allow for the administration of higher B12 doses compared to energy shots
US$ 28.33
US$ 28.74
US$ 28.68
US$ 21.76
